 |
Aptorum Group Limited
APM
|
4.89 |
$ 1.06 |
-0.93 % |
$ 5.78 M |
China |
 |
Adagene
ADAG
|
53.8 |
$ 1.65 |
- |
$ 92.9 M |
China |
 |
Arrowhead Pharmaceuticals
ARWR
|
8.75 |
$ 64.9 |
-0.15 % |
$ 8.68 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 |
- |
- |
$ 40.3 B |
USA |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Biogen
BIIB
|
452 |
$ 187.4 |
0.75 % |
$ 27.3 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Albireo Pharma
ALBO
|
40.8 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Midatech Pharma plc
MTP
|
245 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
BioXcel Therapeutics
BTAI
|
244 |
$ 1.98 |
-1.0 % |
$ 5.02 M |
USA |
 |
CASI Pharmaceuticals
CASI
|
135 |
$ 1.04 |
-2.34 % |
$ 142 M |
USA |
 |
Catalyst Biosciences
CBIO
|
410 |
$ 10.74 |
-2.1 % |
$ 707 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
946 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
86.5 |
$ 27.0 |
-1.28 % |
$ 1.74 M |
USA |
 |
Cellectis S.A.
CLLS
|
136 |
$ 4.42 |
-1.34 % |
$ 116 M |
France |
 |
Институт стволовых клеток человека
ISKJ
|
104 |
- |
- |
- |
Russia |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
195 |
$ 27.75 |
0.02 % |
$ 1.34 B |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
408 |
$ 11.13 |
-2.02 % |
$ 720 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
436 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Axon Enterprise
AXON
|
116 |
$ 633.45 |
3.34 % |
$ 48 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Aytu BioScience
AYTU
|
360 |
$ 2.64 |
-0.75 % |
$ 16.6 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
6.09 |
- |
-9.72 % |
$ 5.89 M |
USA |